Crestwell Healthcare Limited
22.49
PKR
-0.48
(-2.09%)
Crestwell Healthcare Limited
PSX:SGPL
(Pakistan Stock Exchange)
Recent
price
22.49
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Crestwell Healthcare Limited, formerly known as S. G. Power Limited, is a Pakistan-based healthcare and life sciences company engaged in the import, manufacturing, marketing, distribution, and technical maintenance of medical equipment, disposable medical devices, and pharmaceutical products. The company provides a diversified range of medical and pharmaceutical solutions, structured across core product and service categories that include medical consumables and disposables, such as hypodermic syringes, intravenous (IV) cannulas, surgical dressings, and single-use clinical supplies; medical machinery and diagnostic equipment, such as patient monitoring systems, therapeutic instruments, and specialized hospital tools; pharmaceutical and medicinal formulations, such as prescription therapies, chemical preparations, over-the-counter remedies, and vitamin and dietary supplements; and healthcare support operations, such as equipment installation, calibration, preventive maintenance, and technical after-sales repair services. Crestwell Healthcare Limited serves a wide client base comprising public and private hospital networks, clinical laboratories, government health institutions, non-governmental healthcare organizations, and pharmaceutical distributors across Pakistan. Founded on February 10, 1994, and historically associated with S. G. Allied Businesses Limited as an independent power generation provider, the company is headquartered in Karachi, Pakistan, and is publicly listed on the Pakistan Stock Exchange under the ticker SGPL. In recent developments, the company completed a major strategic restructuring to pivot its primary business model from electric power generation to the healthcare sector, formally changing its name from S. G. Power Limited to Crestwell Healthcare Limited with regulatory approval from the Securities and Exchange Commission of Pakistan (SECP) in August 2026. To fund this operational transformation, the company announced a 300% rights share offering to finance working capital, secure Drug Regulatory Authority of Pakistan (DRAP) product registrations, and execute the planned acquisition of a 50% equity stake in a pharmaceutical manufacturing firm, alongside entering strategic distribution alliances, including arrangements for the commercial distribution of specialized medical products such as Nipro hospital lines.